Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer
Twenty patients with small cell lung cancer (SCLC) were entered to the study. Fourteen cases were male and six cases were female. Twelve cases were extensive disease, eight cases were limited disease. Median age was 60 years (range = 40-72 years), median performance status was 70 per cent (range = 6...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | Clinical Trial |
| اللغة: | English |
| منشور في: |
2014
|
| الوصول للمادة أونلاين: | http://www.ncbi.nlm.nih.gov/pubmed/3502482 http://cmuir.cmu.ac.th/handle/6653943832/3310 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|